Skip to main content
Top
Published in: Insights into Imaging 1/2023

Open Access 01-12-2023 | Pathology | Original article

Integrative diagnostics: the time is now—a report from the International Society for Strategic Studies in Radiology

Authors: Norman J. Beauchamp, R. Nick Bryan, Marilyn M. Bui, Gabriel P. Krestin, Geraldine B. McGinty, Carolyn C. Meltzer, Michael Neumaier

Published in: Insights into Imaging | Issue 1/2023

Login to get access

Abstract

Enormous recent progress in diagnostic testing can enable more accurate diagnosis and improved clinical outcomes. Yet these tests are increasingly challenging and frustrating; the volume and diversity of results may overwhelm the diagnostic acumen of even the most dedicated and experienced clinician. Because they are gathered and processed within the “silo” of each diagnostic discipline, diagnostic data are fragmented, and the electronic health record does little to synthesize new and existing data into usable information. Therefore, despite great promise, diagnoses may still be incorrect, delayed, or never made. Integrative diagnostics represents a vision for the future, wherein diagnostic data, together with clinical data from the electronic health record, are aggregated and contextualized by informatics tools to direct clinical action. Integrative diagnostics has the potential to identify correct therapies more quickly, modify treatment when appropriate, and terminate treatment when not effective, ultimately decreasing morbidity, improving outcomes, and avoiding unnecessary costs. Radiology, laboratory medicine, and pathology already play major roles in medical diagnostics. Our specialties can increase the value of our examinations by taking a holistic approach to their selection, interpretation, and application to the patient’s care pathway. We have the means and rationale to incorporate integrative diagnostics into our specialties and guide its implementation in clinical practice.

Graphic abstract

Literature
1.
go back to reference Saber Tehrani AS, Lee H, Mathews SC et al (2013) 25-Year summary of US malpractice claims for diagnostic errors 1986–2010: an analysis from the National Practitioner Data Bank. BMJ Qual Saf 22:672–680CrossRefPubMed Saber Tehrani AS, Lee H, Mathews SC et al (2013) 25-Year summary of US malpractice claims for diagnostic errors 1986–2010: an analysis from the National Practitioner Data Bank. BMJ Qual Saf 22:672–680CrossRefPubMed
3.
go back to reference Schwartz A, Elstein AS (2008) Clinical reasoning in medicine. In: Higgs J, Jones M, Loftus S, Christensen N (eds) Clinical reasoning in the health professions, 3rd edn. Elsevier, Boston, pp 223–234 Schwartz A, Elstein AS (2008) Clinical reasoning in medicine. In: Higgs J, Jones M, Loftus S, Christensen N (eds) Clinical reasoning in the health professions, 3rd edn. Elsevier, Boston, pp 223–234
5.
go back to reference Van Leeuwen AM, Bladh ML (2021) Davis’s comprehensive manual of laboratory and diagnostic tests with nursing implications, 9th edn. F. A. Davis, Philadelphia Van Leeuwen AM, Bladh ML (2021) Davis’s comprehensive manual of laboratory and diagnostic tests with nursing implications, 9th edn. F. A. Davis, Philadelphia
6.
go back to reference Lippi G, Plebani M (2020) Integrated diagnostics: the future of laboratory medicine? Biochem Med (Zagreb) 30:010501CrossRefPubMed Lippi G, Plebani M (2020) Integrated diagnostics: the future of laboratory medicine? Biochem Med (Zagreb) 30:010501CrossRefPubMed
7.
go back to reference Balogh EP, Miller BT, Ball JR (eds) (2015) Improving diagnosis in health care. The National Academies Press, Washington, DC Balogh EP, Miller BT, Ball JR (eds) (2015) Improving diagnosis in health care. The National Academies Press, Washington, DC
8.
go back to reference Stern SDC, Cifu AS, Altkorn D (2015) Symptom to diagnosis: an evidence-based guide, 3rd edn. Lange, New York Stern SDC, Cifu AS, Altkorn D (2015) Symptom to diagnosis: an evidence-based guide, 3rd edn. Lange, New York
9.
go back to reference Lundberg GD (1990) Critical (panic) value notification: an established laboratory practice policy (parameter). JAMA 263:709CrossRefPubMed Lundberg GD (1990) Critical (panic) value notification: an established laboratory practice policy (parameter). JAMA 263:709CrossRefPubMed
11.
go back to reference Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R (2013) The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS ONE 8:e78962CrossRefPubMedPubMedCentral Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R (2013) The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS ONE 8:e78962CrossRefPubMedPubMedCentral
12.
go back to reference Hughes DR, Jiang M, Duszak R Jr (2015) A comparison of diagnostic imaging ordering patterns between advanced practice clinicians and primary care physicians following office-based evaluation and management visits. JAMA Intern Med 175:101–107CrossRefPubMed Hughes DR, Jiang M, Duszak R Jr (2015) A comparison of diagnostic imaging ordering patterns between advanced practice clinicians and primary care physicians following office-based evaluation and management visits. JAMA Intern Med 175:101–107CrossRefPubMed
13.
go back to reference Berner ES (2009) Clinical decision support systems: state of the art. Rockville, MD: Agency for Healthcare Research and Quality Berner ES (2009) Clinical decision support systems: state of the art. Rockville, MD: Agency for Healthcare Research and Quality
14.
go back to reference Blackmore CC, Mecklenburg RS, Kaplan GS (2011) Effectiveness of clinical decision support in controlling inappropriate imaging. J Am Coll Radiol 8:19–25CrossRefPubMed Blackmore CC, Mecklenburg RS, Kaplan GS (2011) Effectiveness of clinical decision support in controlling inappropriate imaging. J Am Coll Radiol 8:19–25CrossRefPubMed
15.
go back to reference Were MC, Shen C, Tierney WM et al (2011) Evaluation of computer-generated reminders to improve CD4 laboratory monitoring in sub-Saharan Africa: a prospective comparative study. J Am Med Inform Assoc 18:150–155CrossRefPubMedPubMedCentral Were MC, Shen C, Tierney WM et al (2011) Evaluation of computer-generated reminders to improve CD4 laboratory monitoring in sub-Saharan Africa: a prospective comparative study. J Am Med Inform Assoc 18:150–155CrossRefPubMedPubMedCentral
18.
go back to reference Ebinger M, Siegerink B, Kunz A et al (2021) Association between dispatch of mobile stroke units and functional outcomes among patients with acute ischemic stroke in Berlin. JAMA 325:454–466CrossRefPubMedPubMedCentral Ebinger M, Siegerink B, Kunz A et al (2021) Association between dispatch of mobile stroke units and functional outcomes among patients with acute ischemic stroke in Berlin. JAMA 325:454–466CrossRefPubMedPubMedCentral
19.
go back to reference Lu MT, Rosman DA, Wu CC et al (2016) Radiologist point-of-care clinical decision support and adherence to guidelines for incidental lung nodules. J Am Coll Radiol 13:156–162CrossRefPubMed Lu MT, Rosman DA, Wu CC et al (2016) Radiologist point-of-care clinical decision support and adherence to guidelines for incidental lung nodules. J Am Coll Radiol 13:156–162CrossRefPubMed
20.
go back to reference Zwaan L, Thijs A, Wagner C, Timmermans DR (2013) Does inappropriate selectivity in information use relate to diagnostic errors and patient harm? The diagnosis of patients with dyspnea. Soc Sci Med 91:32–38CrossRefPubMed Zwaan L, Thijs A, Wagner C, Timmermans DR (2013) Does inappropriate selectivity in information use relate to diagnostic errors and patient harm? The diagnosis of patients with dyspnea. Soc Sci Med 91:32–38CrossRefPubMed
21.
go back to reference Wahls TL, Cram PM (2007) The frequency of missed test results and associated treatment delays in a highly computerized health system. BMC Fam Pract 8:32CrossRefPubMedPubMedCentral Wahls TL, Cram PM (2007) The frequency of missed test results and associated treatment delays in a highly computerized health system. BMC Fam Pract 8:32CrossRefPubMedPubMedCentral
26.
go back to reference Riches N, Panagioti M, Alam R et al (2016) The effectiveness of electronic differential diagnoses (DDX) generators: a systematic review and meta-analysis. PLoS ONE 11:e0148991CrossRefPubMedPubMedCentral Riches N, Panagioti M, Alam R et al (2016) The effectiveness of electronic differential diagnoses (DDX) generators: a systematic review and meta-analysis. PLoS ONE 11:e0148991CrossRefPubMedPubMedCentral
27.
go back to reference US Department of Health and Human Services (2020) 21st Century Cures Act: interoperability, information blocking, and the ONC Health IT certification program. Fed Reg 85:25642–25961 US Department of Health and Human Services (2020) 21st Century Cures Act: interoperability, information blocking, and the ONC Health IT certification program. Fed Reg 85:25642–25961
29.
go back to reference Pelsers MM, Hanhoff T, Van der Voort D et al (2004) Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 50:1568–1575CrossRefPubMed Pelsers MM, Hanhoff T, Van der Voort D et al (2004) Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 50:1568–1575CrossRefPubMed
30.
go back to reference Elster AB, Callan CM, American MA (2002) Physician roles in medicine-public health collaboration: future directions of the American Medical Association. Am J Prev Med 22:211–213CrossRefPubMed Elster AB, Callan CM, American MA (2002) Physician roles in medicine-public health collaboration: future directions of the American Medical Association. Am J Prev Med 22:211–213CrossRefPubMed
31.
go back to reference Emerson MA, Golightly YM, Aiello AE et al (2020) Breast cancer treatment delays by socioeconomic and health care access latent classes in black and white women. Cancer 126:4957–4966CrossRefPubMed Emerson MA, Golightly YM, Aiello AE et al (2020) Breast cancer treatment delays by socioeconomic and health care access latent classes in black and white women. Cancer 126:4957–4966CrossRefPubMed
33.
go back to reference Sherman RE, Anderson SA, Dal Pan GJ et al (2016) Real-world evidence—what is it and what can it tell us? N Engl J Med 375:2293–2297CrossRefPubMed Sherman RE, Anderson SA, Dal Pan GJ et al (2016) Real-world evidence—what is it and what can it tell us? N Engl J Med 375:2293–2297CrossRefPubMed
34.
go back to reference Bate E, Hommes J, Duvivier R, Taylor DC (2014) Problem-based learning (PBL): getting the most out of your students—their roles and responsibilities: AMEE Guide No. 84. Med Teach 36:1–12CrossRefPubMed Bate E, Hommes J, Duvivier R, Taylor DC (2014) Problem-based learning (PBL): getting the most out of your students—their roles and responsibilities: AMEE Guide No. 84. Med Teach 36:1–12CrossRefPubMed
35.
go back to reference Porter ME, Lee TH (2021) Integrated practice units: a playbook for health care leaders. NEJM Catal Innovations in Care Delivery Porter ME, Lee TH (2021) Integrated practice units: a playbook for health care leaders. NEJM Catal Innovations in Care Delivery
36.
go back to reference Jha S, Topol EJ (2016) Adapting to artificial intelligence: radiologists and pathologists as information specialists. JAMA 316:2353–2354CrossRefPubMed Jha S, Topol EJ (2016) Adapting to artificial intelligence: radiologists and pathologists as information specialists. JAMA 316:2353–2354CrossRefPubMed
40.
go back to reference Ponti G, Maccaferri M, Percesepe A, Tomasi A, Ozben T (2021) Liquid biopsy with cell free DNA: new horizons for prostate cancer. Crit Rev Clin Lab Sci 58:60–76CrossRefPubMed Ponti G, Maccaferri M, Percesepe A, Tomasi A, Ozben T (2021) Liquid biopsy with cell free DNA: new horizons for prostate cancer. Crit Rev Clin Lab Sci 58:60–76CrossRefPubMed
41.
go back to reference Gao Y, Zhang M, Li X, Zeng P, Wang P, Zhang L (2019) Serum PSA levels in patients with prostate cancer and other 33 different types of diseases. Prog Mol Biol Transl Sci 162:377–390CrossRefPubMed Gao Y, Zhang M, Li X, Zeng P, Wang P, Zhang L (2019) Serum PSA levels in patients with prostate cancer and other 33 different types of diseases. Prog Mol Biol Transl Sci 162:377–390CrossRefPubMed
42.
go back to reference Bhalla A, Zulfiqar M, Bluth MH (2018) Molecular diagnostics in colorectal carcinoma: advances and applications for 2018. Clin Lab Med 38:311–342CrossRefPubMed Bhalla A, Zulfiqar M, Bluth MH (2018) Molecular diagnostics in colorectal carcinoma: advances and applications for 2018. Clin Lab Med 38:311–342CrossRefPubMed
43.
go back to reference Delgado JA, Ballesteros MA, Parera MM, Bauca JM (2021) Pancreatic cancer insights: optimization of the diagnostic capacity of tumor biomarkers. Lab Med 52:550–557CrossRefPubMed Delgado JA, Ballesteros MA, Parera MM, Bauca JM (2021) Pancreatic cancer insights: optimization of the diagnostic capacity of tumor biomarkers. Lab Med 52:550–557CrossRefPubMed
44.
go back to reference Li X, Xu Y, Zhang L (2019) Serum CA153 as biomarker for cancer and noncancer diseases. Prog Mol Biol Transl Sci 162:265–276CrossRefPubMed Li X, Xu Y, Zhang L (2019) Serum CA153 as biomarker for cancer and noncancer diseases. Prog Mol Biol Transl Sci 162:265–276CrossRefPubMed
45.
go back to reference Heizmann CW (2019) S100 proteins: diagnostic and prognostic biomarkers in laboratory medicine. Biochim Biophys Acta Mol Cell Res 1866:1197–1206CrossRefPubMed Heizmann CW (2019) S100 proteins: diagnostic and prognostic biomarkers in laboratory medicine. Biochim Biophys Acta Mol Cell Res 1866:1197–1206CrossRefPubMed
46.
go back to reference Wang H, Zhang J, Li X et al (2020) The utilization pattern of serum tumor markers in lung cancer patients: a population-based retrospective descriptive study. J Clin Lab Anal 34:e23465CrossRefPubMedPubMedCentral Wang H, Zhang J, Li X et al (2020) The utilization pattern of serum tumor markers in lung cancer patients: a population-based retrospective descriptive study. J Clin Lab Anal 34:e23465CrossRefPubMedPubMedCentral
47.
go back to reference Milani P, Palladini G, Merlini G (2016) Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions. Scand J Clin Lab Invest Suppl 245:S113–S118CrossRefPubMed Milani P, Palladini G, Merlini G (2016) Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions. Scand J Clin Lab Invest Suppl 245:S113–S118CrossRefPubMed
48.
go back to reference Shi M, Xiao R, Woda BA, Yu H (2014) Five important advances in hematopathology. Arch Pathol Lab Med 138:410–419CrossRefPubMed Shi M, Xiao R, Woda BA, Yu H (2014) Five important advances in hematopathology. Arch Pathol Lab Med 138:410–419CrossRefPubMed
53.
go back to reference Goldsmith JF, Herskovits AZ (2020) Cerebrospinal fluid testing for multiple sclerosis. Clin Lab Med 40:369–377CrossRefPubMed Goldsmith JF, Herskovits AZ (2020) Cerebrospinal fluid testing for multiple sclerosis. Clin Lab Med 40:369–377CrossRefPubMed
54.
go back to reference Schuurman AR, Reijnders TDY, Kullberg RFJ, Butler JM, van der Poll T, Wiersinga WJ (2021) Sepsis: deriving biological meaning and clinical applications from high-dimensional data. Intens Care Med Exp 9:27CrossRef Schuurman AR, Reijnders TDY, Kullberg RFJ, Butler JM, van der Poll T, Wiersinga WJ (2021) Sepsis: deriving biological meaning and clinical applications from high-dimensional data. Intens Care Med Exp 9:27CrossRef
55.
go back to reference Espinoza G, Maldonado G, Narvaez J, Guerrero R, Citera G, Rios C (2021) Beyond rheumatoid arthritis evaluation: What are we missing? Open Access Rheumatol 13:45–55CrossRefPubMedPubMedCentral Espinoza G, Maldonado G, Narvaez J, Guerrero R, Citera G, Rios C (2021) Beyond rheumatoid arthritis evaluation: What are we missing? Open Access Rheumatol 13:45–55CrossRefPubMedPubMedCentral
56.
go back to reference Petrovska N, Prajzlerova K, Vencovsky J, Senolt L, Filkova M (2021) The pre-clinical phase of rheumatoid arthritis: from risk factors to prevention of arthritis. Autoimmun Rev 20:102797CrossRefPubMed Petrovska N, Prajzlerova K, Vencovsky J, Senolt L, Filkova M (2021) The pre-clinical phase of rheumatoid arthritis: from risk factors to prevention of arthritis. Autoimmun Rev 20:102797CrossRefPubMed
57.
go back to reference Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J Endocrinol Invest 42:1407–1433CrossRefPubMed Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J Endocrinol Invest 42:1407–1433CrossRefPubMed
58.
go back to reference Stavropoulos K, Imprialos K, Papademetriou V et al (2020) Primary aldosteronism: novel insights. Curr Hypertens Rev 16:19–23PubMed Stavropoulos K, Imprialos K, Papademetriou V et al (2020) Primary aldosteronism: novel insights. Curr Hypertens Rev 16:19–23PubMed
59.
go back to reference Honegger J, Buchfelder M, Schlaffer S et al (2015) Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 100:3460–3469CrossRefPubMed Honegger J, Buchfelder M, Schlaffer S et al (2015) Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 100:3460–3469CrossRefPubMed
60.
go back to reference Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E (2021) Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes 12:344–365CrossRefPubMedPubMedCentral Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E (2021) Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes 12:344–365CrossRefPubMedPubMedCentral
61.
go back to reference Supabphol S, Seubwai W, Wongkham S, Saengboonmee C (2021) High glucose: an emerging association between diabetes mellitus and cancer progression. J Mol Med (Berl) 99:1175–1193CrossRefPubMed Supabphol S, Seubwai W, Wongkham S, Saengboonmee C (2021) High glucose: an emerging association between diabetes mellitus and cancer progression. J Mol Med (Berl) 99:1175–1193CrossRefPubMed
62.
go back to reference LeGrys VA, Hartmann K, Walsh JF (2004) The clinical consequences and diagnosis of hypothyroidism. Clin Lab Sci 17:203–208PubMed LeGrys VA, Hartmann K, Walsh JF (2004) The clinical consequences and diagnosis of hypothyroidism. Clin Lab Sci 17:203–208PubMed
63.
go back to reference Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Macut D (2019) The complexities in genotyping of congenital adrenal hyperplasia: 21-hydroxylase deficiency. Front Endocrinol (Lausanne) 10:432CrossRefPubMed Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Macut D (2019) The complexities in genotyping of congenital adrenal hyperplasia: 21-hydroxylase deficiency. Front Endocrinol (Lausanne) 10:432CrossRefPubMed
Metadata
Title
Integrative diagnostics: the time is now—a report from the International Society for Strategic Studies in Radiology
Authors
Norman J. Beauchamp
R. Nick Bryan
Marilyn M. Bui
Gabriel P. Krestin
Geraldine B. McGinty
Carolyn C. Meltzer
Michael Neumaier
Publication date
01-12-2023
Publisher
Springer Vienna
Keyword
Pathology
Published in
Insights into Imaging / Issue 1/2023
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-023-01379-9

Other articles of this Issue 1/2023

Insights into Imaging 1/2023 Go to the issue